ūüéČ Health Canada Provides a No Objection Letter for ATMA‚Äôs N500 Phase II Clinical Trial Application

Month: January 2023

ATMA Provides Alberta Health Services (AHS) Healthcare Professionals Group Discount on Psychedelic Therapy Education

CALGARY, ALBERTA, CANADA, January 25, 2023 /EINPresswire.com/ — In response to the new Alberta Regulations on psychedelic assisted therapy,¬†ATMA Journey Centers Inc.¬†(“ATMA”), Canada‚Äôs leading psychedelic-assisted therapy training provider, has announced …

ATMA Provides Alberta Health Services (AHS) Healthcare Professionals Group Discount on Psychedelic Therapy Education Read More »

ATMA and Neuma Centre Partner to Create Access to first of its kind Psilocybin Research Trial in Ontario

KINGSTON, ONTARIO, CANADA, January 5, 2023 /EINPresswire.com/ —¬†ATMA Journey Centers Inc. (“ATMA”), a Canada‚Äôs leading psychedelic-assisted therapy training providers, is pleased to announce their affiliate partnership with¬†Neuma Centre, Kingston‚Äôs first …

ATMA and Neuma Centre Partner to Create Access to first of its kind Psilocybin Research Trial in Ontario Read More »